We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $999B
1-Year Est. Return 46.22%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-16.43%
1 Year Est. Return
+46.22%
3 Year Est. Return
+150.45%
5 Year Est. Return
+185.95%
10 Year Est. Return
+1,389.53%
AUM
$791B
AUM Growth
-$200B
Cap. Flow
-$11.4B
Cap. Flow %
-1.44%
Top 10 Hldgs %
26.42%
Holding
3,063
New
88
Increased
1,490
Reduced
1,207
Closed
101

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$3.46B
2
UNH icon
UnitedHealth
UNH
+$2.79B
3
CRM icon
Salesforce
CRM
+$2.38B
4
SHW icon
Sherwin-Williams
SHW
+$1.41B
5
PM icon
Philip Morris
PM
+$1.34B

Sector Composition

Rank Sector Weight
1 Technology 26.68%
2 Healthcare 19.49%
3 Consumer Discretionary 13.07%
4 Financials 11.18%
5 Communication Services 8.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WTFC icon
1851
Wintrust Financial
WTFC
$11B
$1.09M ﹤0.01%
13,617
+2,006
+17% +$173K
KW
1852
DELISTED
Kennedy-Wilson Holdings
KW
$1.09M ﹤0.01%
57,469
+590
+1% +$12.7K
PACI.U
1853
DELISTED
PROOF Acquisition Corp I Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
PACI.U
$1.08M ﹤0.01%
110,750
FHB icon
1854
First Hawaiian
FHB
$3.38B
$1.08M ﹤0.01%
47,505
+1,562
+3% +$39.2K
WGO icon
1855
Winnebago Industries
WGO
$892M
$1.07M ﹤0.01%
22,087
+192
+0.9% +$9.92K
AMBA icon
1856
Ambarella
AMBA
$3.54B
$1.07M ﹤0.01%
16,358
-1,198
-7% -$96.5K
IJH icon
1857
iShares Core S&P Mid-Cap ETF
IJH
$128B
$1.07M ﹤0.01%
23,565
PECO icon
1858
Phillips Edison & Co
PECO
$5.22B
$1.07M ﹤0.01%
31,912
+13,655
+75% +$464K
SPB icon
1859
Spectrum Brands
SPB
$2.06B
$1.06M ﹤0.01%
12,965
+3,263
+34% +$280K
ACH
1860
Accendra Health
ACH
$80.7M
$1.06M ﹤0.01%
33,774
+767
+2% +$27.8K
NKTR icon
1861
Nektar Therapeutics
NKTR
$2.49B
$1.06M ﹤0.01%
18,617
+11,685
+169% +$737K
AROC icon
1862
Archrock
AROC
$6.01B
$1.06M ﹤0.01%
127,914
+914
+0.7% +$8.37K
AEL
1863
DELISTED
American Equity Investment Life Holding Company
AEL
$1.06M ﹤0.01%
28,934
+4
+0% +$152
SLGN icon
1864
Silgan Holdings
SLGN
$4.46B
$1.05M ﹤0.01%
25,520
-321
-1% -$14.1K
IRWD icon
1865
Ironwood Pharmaceuticals
IRWD
$684M
$1.05M ﹤0.01%
91,397
-153
-0.2% -$1.8K
PGTI
1866
DELISTED
PGT, Inc.
PGTI
$1.05M ﹤0.01%
63,226
+462
+0.7% +$8.31K
GNW icon
1867
Genworth Financial
GNW
$3.82B
$1.05M ﹤0.01%
297,850
-3,762
-1% -$14.4K
RCM
1868
DELISTED
R1 RCM Inc. Common Stock
RCM
$1.05M ﹤0.01%
50,094
+10,163
+25% +$231K
UFCS icon
1869
United Fire Group
UFCS
$1.38B
$1.05M ﹤0.01%
30,613
+187
+0.6% +$5.83K
LSXMA
1870
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$1.04M ﹤0.01%
39,427
-11,542
-23% -$346K
DRH icon
1871
Diamondrock Hospitality Co
DRH
$2.53B
$1.04M ﹤0.01%
127,027
+1,485
+1% +$14.5K
EPC icon
1872
Edgewell Personal Care
EPC
$1.32B
$1.04M ﹤0.01%
30,227
+238
+0.8% +$8.56K
QQQ icon
1873
Invesco QQQ Trust
QQQ
$485B
$1.04M ﹤0.01%
3,715
H icon
1874
Hyatt Hotels
H
$17B
$1.04M ﹤0.01%
14,066
+556
+4% +$48.2K
HAFC icon
1875
Hanmi Financial
HAFC
$963M
$1.03M ﹤0.01%
46,107
+5,756
+14% +$134K

Similar funds

T. Rowe Price Associates's Q2 2022 Portfolio in Review

As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
  • T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
  • T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
  • T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
  • T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
  • T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.

Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.